CEP-28122 mesylate salt (1022958-60-6 free base) NEW
Price | $39 | $79 | $123 |
Package | 1mg | 5mg | 10mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2024-11-18 |
Product Details
Product Name: CEP-28122 mesylate salt (1022958-60-6 free base) | Purity: 99.79% |
Supply Ability: 10g | Release date: 2024/11/18 |
Product Introduction
Bioactivity
名稱 | CEP-28122 mesylate salt (1022958-60-6 free base) |
描述 | CEP-28122 mesylate salt (1022958-60-6 free base) is a highly selective orally active ALK inhibitor (IC50: 1.9 nM in an enzyme-based TRF assay). |
體外活性 | CEP-28122 is a potent inhibitor of recombinant ALK activity and cellular ALK tyrosine phosphorylation. CEP-28122 also inhibits Flt4 (IC50: 46 nM). CEP-28122 induces concentration-dependent growth inhibition/cytotoxicity of ALK-positive anaplastic large-cell lymphoma (ALCL), neuroblastoma cells, and non-small cell lung cancer (NSCLC). |
體內(nèi)活性 | CEP-28122 displays dose-dependent inhibition of ALK tyrosine phosphorylation in tumor xenografts in mice, with substantial target inhibition (>90%) for more than12 hours following single oral dosing at 30 mg/kg. Dose-dependent antitumor activity was observed in ALK-positive ALCL, NSCLC, and neuroblastoma tumor xenografts in mice administered CEP-28122 orally, with complete/near-complete tumor regressions observed following treatment at doses of 30 mg/kg twice daily or higher. |
存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 6.4 mg/mL (10.08 mM) |
關(guān)鍵字 | CEP 28122 mesylate salt (1022958 60 6 free base) | 1022958-60-6 | CEP 28122 Mesylate | CEP28122 mesylate salt (1022958606 free base) | CEP-28122 Mesylate | 1022958-60-6 free base | CEP28122 Mesylate |
相關(guān)產(chǎn)品 | Alectinib hydrochloride | Lorlatinib | SB-431542 | DMH-1 | RepSox | Crizotinib | Vactosertib | Ceritinib | LDN-193189 2HCl | Brigatinib | A 83-01 | ALK-IN-1 |
相關(guān)庫 | 高選擇性抑制劑庫 | 經(jīng)典已知活性庫 | 膜蛋白靶向化合物庫 | 酪氨酸激酶分子庫 | 激酶抑制劑庫 | 血液病分子庫 | 抑制劑庫 | NO PAINS 化合物庫 | 已知活性化合物庫 | 抗癌活性化合物庫 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$50.00/1mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-10-25 | |
$137.00/1mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-11-17 | |
$0.00/1kg |
VIP5Y
|
Zison Pharmaceutical (Shandong) Co., Ltd.
|
2024-05-24 | |
$39.00/1mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-11-18 |
- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY